AI Verdict
HGYN has stronger fundamentals based on our AI analysis.
HHS vs HGYN Fundamental Comparison
| Metric | HHS | HGYN |
|---|---|---|
| Revenue | $159.6M | $612,206.0 |
| Net Income | $-811,000.0 | $116,163.0 |
| Net Margin | -0.5% | 19.0% |
| ROE | -4.0% | N/A |
| ROA | -0.9% | 27.0% |
| Current Ratio | 1.54x | 0.85x |
| Debt/Equity | 0.00x | N/A |
| EPS | $-0.11 | $0.00 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HHS vs HGYN: Frequently Asked Questions
Is HHS or HGYN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HGYN has stronger fundamentals. HHS is rated STRONG SELL (88% confidence) while HGYN is rated STRONG SELL (90% confidence). This is not investment advice.
How does HHS compare to HGYN fundamentally?
HARTE HANKS INC has ROE of -4.0% vs HONG YUAN HOLDING GROUP's N/A. Net margins are -0.5% vs 19.0% respectively.
Which stock pays higher dividends, HHS or HGYN?
HHS has a dividend yield of N/A or no dividend while HGYN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HHS or HGYN for long term?
For long-term investing, consider that HHS has STRONG SELL rating with 88% confidence, while HGYN has STRONG SELL rating with 90% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HHS vs HGYN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HHS vs HGYN, the AI consensus favors HGYN based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.